U.S. Mortgage Finance Stock News

Apogee Therapeutics (APGE) stock is in focus after positive 16-week Phase 2 APEX data for zumilokibart in atopic dermatitis, followed by a milestone-based, non-dilutive financing package of up to US$1.3b from Blackstone Life Sciences. See our latest analysis for Apogee Therapeutics. After a sharp rally tied to the Phase 2 APEX data and US$1.3b Blackstone financing, Apogee’s share price has eased 4.5% over the last day, although the 1-year total shareholder return of 106.85% points to strong...

Recent share performance and business profile Charles River Laboratories International (CRL) has drawn investor attention after recent share price moves, with the stock up about 5% over the past month and roughly 11% over the past 3 months. The company provides drug discovery, non clinical development, and safety testing services. It generates about US$4.0b in revenue and operates across the United States, Europe, Canada, and the Asia Pacific region. See our latest analysis for Charles River...

Recently, Allegiant Travel Company completed a private fixed-income offering of US$500 million in senior secured notes due 2031, guaranteed by most subsidiaries and backed by substantially all non-aircraft assets. This refinancing move, aimed at replacing existing senior secured notes and funding general corporate purposes, meaningfully reshapes Allegiant’s capital structure and balance-sheet flexibility. Next, we’ll examine how issuing US$500 million in senior secured notes could influence...

In early June 2026, Cisco Systems and partners including NetApp, Splunk, Qumulo, AT&T, and LiveOne announced new AI-centric infrastructure, security, and cloud-management offerings such as Cisco Cloud Control, expanded FlexPod AI solutions, and enhanced ransomware response playbooks. These launches highlight Cisco’s push to fuse AI networking, zero-trust security, and hybrid cloud operations into unified platforms that can simplify deployment and resilience for large enterprises and...

Choice Hotels International (CHH) has drawn fresh attention after promoting longtime technology leader Tony Pallas to Chief Technology Officer, coinciding with its rollout of AI powered tools and broader leadership changes across the company. See our latest analysis for Choice Hotels International. Despite the leadership and AI rollouts, recent trading has been softer, with the share price down 4.0% over one day and 5.5% over seven days. It is still showing a 9.7% year to date share price...

In early June 2026, Helix Energy Solutions Group was affected by heightened tensions between Israel and Iran, as direct strikes between the two countries pushed Brent crude oil briefly toward US$98 a barrel and lifted sentiment across energy-related equities. This episode highlights how shifts in geopolitical risk and resulting moves in oil prices can quickly alter expectations for offshore services demand and profitability for companies such as Helix. We’ll now examine how this spike in...

FDA decision reshapes uniQure’s risk profile The FDA’s refusal to grant accelerated approval for uniQure (NasdaqGS:QURE) Huntington’s disease therapy AMT-130, and its requirement for a full Phase III sham-controlled trial, has sharply reset expectations around timing, cost, and risk for investors. See our latest analysis for uniQure. uniQure’s share price has been volatile, with a 47.86% 90 day share price return and a 59.76% 1 year total shareholder return. Shorter term moves around the FDA...

In early June 2026, Rush Street Interactive, Inc. secured shareholder approval to amend its charter, advanced a major secondary offering by executive-affiliated trusts alongside a new US$100.0 million repurchase plan, and was selected for inclusion in the S&P SmallCap 600 Index later in the month. These moves, combined with continued profitability, raised 2026 guidance, and an application to launch prediction market products, highlight management’s focus on governance, capital flexibility,...

In May 2026, Lumen Technologies’ shareholders approved amendments to its Articles of Incorporation that removed certain supermajority voting requirements in favor of a simple majority standard and narrowed the definition of “Related Person,” while also electing Michael Collins to the board and rejecting a proposal on shareholder voting rights over any future rights plan. Alongside these governance changes, Lumen filed a US$463.75 million employee stock offering shelf and elevated key public...

In June 2026, Fluor Corporation announced that its JGC Fluor BC LNG II joint venture with JGC received a limited notice to proceed for the proposed Phase 2 expansion of the LNG Canada export facility in Kitimat, British Columbia, following its earlier role in delivering Phase 1’s two LNG trains and supporting infrastructure. This early-phase authorization highlights Fluor’s continued involvement in a long-duration LNG project that could significantly extend work visibility if a final...

In May 2026, Guardian Pharmacy Services, Inc. entered into an eighth amendment to its long-standing loan and security agreement, extending the revolving credit facility’s maturity to May 21, 2030, expanding potential borrowing capacity to US$80 million, and updating covenants to a consolidated net leverage ratio framework. This refinancing package gives Guardian more room to manage debt against cash and Adjusted EBITDA, which may influence how investors assess its balance sheet flexibility...

Pfizer (NYSE:PFE) reported positive Phase 2b results for berobenatide, a once monthly GLP-1 obesity drug candidate, and started a global Phase 3 program. The company entered the late stage obesity drug race with a potential first in class monthly GLP-1 therapy aimed at less frequent dosing. Pfizer also received expanded FDA approval for HYMPAVZI in pediatric hemophilia B, opening access for younger patients. The HYMPAVZI update brings a subcutaneous non factor therapy to a pediatric group...

Cabot Corporation recently reported fiscal second-quarter 2026 adjusted earnings that exceeded expectations, supported by robust demand for battery materials tied to energy storage systems and electric vehicle applications, while reaffirming its full-year earnings guidance despite geopolitical uncertainty. An interesting angle for investors is Cabot’s plan to rationalize capacity in South America and Europe to unlock ongoing fixed-cost savings while using price increases to help preserve...

CPS Technologies (CPSH) has filed a follow-on equity offering to raise US$9.6 million by issuing 1,200,000 common shares at US$8 each in a registered direct deal, introducing fresh capital and potential dilution. See our latest analysis for CPS Technologies. The follow on offering comes after a sharp run, with a 30 day share price return of 95.21% and year to date share price return of 142.19%. The 1 year total shareholder return of 181.82% points to strong longer term momentum despite...

Tarsus Pharmaceuticals (TARS) has been drawing attention after recent trading swings, with the stock closing at US$59.64 while showing mixed returns over the past month and past 3 months, alongside a positive one year track record. See our latest analysis for Tarsus Pharmaceuticals. The share price has been under pressure in recent months, with a 90 day share price return down 18.32% and year to date share price return down 26.16%. At the same time, the 1 year total shareholder return sits at...

Earlier this month, APA Corporation filed an US$880.15 million shelf registration for 24,160,000 common shares in an ESOP-related offering, following a first-quarter 2026 earnings report that exceeded expectations on higher realized oil prices and lower expenses. This combination of an ESOP-focused equity registration and profit support from cost control highlights how APA is pairing employee ownership with operational discipline. Next, we’ll examine how stronger-than-expected earnings,...

Lumentum Holdings recently raised its fourth-quarter guidance and reported very large year-over-year revenue growth, citing intense AI-driven demand for its cloud networking and optical components, while also executing a US$650.4 million private exchange of convertible notes for equity to reduce debt. At the same time, the company secured a multi-year US$2 billion agreement with Nvidia and is expanding manufacturing capacity, including an indium phosphide fab in North Carolina, highlighting...

Event context and recent stock performance Palvella Therapeutics (PVLA) has drawn fresh attention after recent trading saw the stock close at US$105.25. This move comes alongside a year-to-date gain of 5% and a 1-year total return near 3x. See our latest analysis for Palvella Therapeutics. Recent trading has been choppy, with the share price down 3.15% on the day, 6.52% over the past week and 25.94% over the past quarter. At the same time, the 1 year total shareholder return sits near 3x,...

Why Azenta (AZTA) is on investors’ radar today Azenta (AZTA) continues to draw attention after a mixed stretch of performance that includes a gain over the past month but weaker returns year to date and over the past year. With a market value of about US$1.0b and reported revenue of US$596.5m, the company sits in an interesting spot for investors comparing growth potential, profitability and valuation against other life sciences service providers. See our latest analysis for Azenta. At the...

Event context and recent share performance Viavi Solutions (VIAV) has caught investor attention after recent share price moves, with the stock up 2.5% over the past week but down about 4.8% over the past month. Over the past 3 months, Viavi has delivered a gain of about 64%, while the 1 year total return sits around 411%, placing current sentiment in a very different place than earlier periods. See our latest analysis for Viavi Solutions. At a share price of $48.75, the stock has pulled back...

Park Hotels & Resorts (PK) has been drawing attention after its stock price moved over the past month and past 3 months, prompting investors to reassess how the hotel REIT’s fundamentals line up with recent returns. See our latest analysis for Park Hotels & Resorts. The recent share price move to $14.12 sits on top of strong momentum, with a 30-day share price return of 24.73% and a 1-year total shareholder return of 49.33%, although the 5-year total shareholder return is slightly...

Capital Clean Energy Carriers (CCEC) has just expanded its LNG and multi-gas fleet, securing multiple new time charters that lifted its contracted revenue backlog to about US$3.1b, with options increasing this to roughly US$4.6b. See our latest analysis for Capital Clean Energy Carriers. Despite the fresh LNG and multi gas charter wins, the stock has eased recently, with a 1-day share price return of 1.71% lower and a 7-day share price return of 5.5% lower. However, the 30-day share price...

Primoris Services Corporation has appointed Tim Healy, President of ARB Industrial Inc., as Interim President of Renewables following Anthony Vorderbruggen’s departure on June 8, 2026, while it runs an internal and external search for a permanent replacement. The move places an experienced operator with long-standing construction and execution expertise at the helm of a renewables segment that Primoris has identified as a key growth focus. Next, we’ll examine how Tim Healy’s interim...

Recent share performance context Church & Dwight (CHD) has seen mixed share performance recently, with a small decline over the past day, flat movement over the past week, and a modest gain over the past month. Over the past 3 months, the stock is down, although the year to date return is positive and the 3 year and 5 year total returns are also positive. This provides context for assessing today’s valuation and fundamentals. See our latest analysis for Church & Dwight. At a share price of...